Oncologists Generally Refer to Specialized Palliative Care Late

This article originally appeared here.
Share this content:
Oncologists Generally Refer to Specialized Palliative Care Late
Oncologists Generally Refer to Specialized Palliative Care Late

(HealthDay News) -- Definitional issues and non-acceptance of patients receiving chemotherapy are the barriers to earlier referral to specialized palliative care (SPC) by oncologists, according to a study published online Oct. 29 in the Journal of Clinical Oncology.

Kirsten Wentlandt, M.D., Ph.D., from the University of Toronto, and colleagues anonymously surveyed physician members of the Canadian Association of Medical Oncologists, Canadian Association of Radiation Oncologists, and Canadian Society of Surgical Oncology regarding SPC referral practices.

The researchers found that, of the 603 participating physicians among 839 surveyed, 94 percent reported that SPC was available to them, but only 37 percent said that these services accepted patients on chemotherapy. Terminally ill patients were usually/always referred by 84 percent of reporting physicians, but generally for uncontrolled symptoms or discharge planning late in the disease course. If SPC was renamed supportive care, one-third of physicians said they would refer earlier. Comprehensiveness of available SPC services, satisfaction with SPC availability, SPC acceptance of patients receiving chemotherapy, and oncologist ease with referring patients to a palliative care service before they were close to death were the factors significantly predictive of higher referral frequency.

"Oncologists referred patients frequently to SPC, but generally late in the disease course for patients with uncontrolled symptoms," the authors write.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs